Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	861.25M -31.2%
Revenue (ttm)	196.15M +4.7%
Net Income	-39.52M
EPS	-0.40
Shares Out	99.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,345
Open	9.02
Previous Close	9.01
Day's Range	8.55 - 9.12
52-Week Range	8.20 - 18.32
Beta	0.79
Analysts	Buy
Price Target	18.00 (0.0%)
Earnings Date	Jul 17, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 116
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.